Sign in / Join Now
ETFs & Funds
Biotech co $
up 70% since 11/15 IPO on fairly low volume. Only one major drug in late-stage development. I'd be wary of this one.
Add a reply...
Latest StockTalks »
people get RLYP breaking news and analysis by email alert.
Get email alerts on RLYP »
Get latest price
From other sites
Wainwright Says Relypsa Takeout Price Is Fair
at Benzinga (Fri, 8:35AM)
Mid-Day Market Update: Relypsa Jumps Following Acquisition News; Essendant Shares Drop
at Benzinga (Thu, 12:16PM)
Galencia's Bid For Relypsa Is 'Reasonable,' Another Bidder 'Unlikely'
at Benzinga (Thu, 10:17AM)
Galenica To Acquire Relypsa For $32 A Share
at Benzinga (Thu, 7:43AM)
'Steady Growth' For Relypsa's Veltassa Launch
at Benzinga (Jul 12, 2016)